Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2231-2240 of 2760 for cancer

Edit search filters
  1. A Study of a New Molecular Approach to Blood DNA Screening for Cancer

    Rochester, MN

  2. A Study To Examine Quality of Life Assessment in Patients Receiving Cryotherapy for Palliation of Dysphagia in Unresectable Esophageal or Gastroesophageal Junctional Cancer

    Scottsdale/Phoenix, AZ

  3. A Study to Analyze the Prevalence of Depression and Anxiety in Newly-diagnosed Breast Cancer Patients in a Community Hospital

    La Crosse, WI, Albert Lea, MN, Austin, MN, Eau Claire, WI, Rochester, MN

  4. A Study to Quantify Microvasculature Imaging for Breast Cancer Detection and Monitoring

    Rochester, MN

  5. Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

    Jacksonville, FL

  6. A Study to Evaluate Remote Monitoring in Cancer Care

    Rochester, MN

  7. A Study to Evaluate Personalized Molecular Marker and Immunoprofiling to Transform Hepatocellular Carcinoma Treatment

    Jacksonville, FL

  8. Understanding Facilitators and Barriers that Impact Capacity and Workload for Caregivers of Metastatic Cancer Patients

    Jacksonville, FL, Rochester, MN

  9. A Study of Circulating Tumor DNA as a Biomarker of a Complete Response of Disease for Advanced Gastroesophageal Adenocarcinoma

    Scottsdale/Phoenix, AZ

  10. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

    Rochester, MN

.

Mayo Clinic Footer